11/4/2024How AstraZeneca Bilked China's Insurance Program Out of CNY Millions (...

11/4/2024Probe of AstraZeneca Executive in China Raises Questions about Company...

10/31/2024China Investigation of Drug Firm Exec Deals Latest Blow to Foreign Bus...

10/31/2024AstraZeneca's China Legal Woes Follow Push For Market Share (Bloomberg...

10/30/2024China's Compliance Guidelines for Healthcare Companies Signal Areas of...

10/29/2024VCs Move to Launch U.S.-Based Companies to Advance Drugs Developed in ...

10/24/2024Patent Term Extensions In China: Overviews And Takeaways (Mondaq)

10/24/2024Reinventing Your China Strategy: A Podcast Preview of the China Health...

10/24/2024U.S. and China Compete for Top Position in the Global Drug Development...

10/21/2024Changing Chinese Market Dynamics Hit Merck Where It Hurts (SCRIP Citel...

10/21/2024Clinical Benefit, Price, and Regulatory Approval of Cancer Drugs Grant...

10/16/2024As U.S. Efforts Stall, China Pushes Ahead with CRISPR Treatments for M...

10/16/2024Understanding the NewCo Model: A Trending Approach of Chinese Pharmace...

10/16/2024China Biopharma Tracker – Q3 2024 (PharmaDJ)

10/16/2024China's New Policies On Foreign Investment In Healthcare And Biotechno...

10/8/2024NRDL China: 2024 Outlook (Simon Kucher)

10/1/2024China's Pharmaceutical Antimonopoly Guidelines Pose New Challenges for...

9/27/2024Pharma Companies in Beijing Free Trade Zone to Benefit from Relaxed Da...

9/23/2024Is Biotech the Next Battleground in US-China Decoupling? (SCMP)

9/20/2024Why 'Big Pharma' Will be the Next China Trade War Battleground (Invest...

9/20/2024Another Twist in the Biosecure Drama Leaves Bill's Fate Uncertain

9/19/2024China's Implementation of Patent Term Adjustment (SM)

9/17/2024Biopharma Prepares to Pivot from China as Biosecure Act Advances (Phar...

9/12/2024China Biopharma Tracker – August 2024 (PharmaDJ)

9/12/2024Equity Investment + Licensing: The NewCo Model Paves a New Path for Ch...

9/11/2024NewCo Model Gains Traction among Chinese Biotechs (ThePharmaLetter)

9/11/2024China Boosts Regulatory Framework for Local Pharmaceutical Manufacturi...

9/10/2024China Opens Doors to Foreign Investment in Cell Therapy and Wholly For...

9/4/2024Report on Emerging Trends and Implications of Non-communicable Disease...

9/4/2024Acceleration in China+1 trend in Pharmaceuticals Sector! (HDFC)

Page:4/6 Total number of articles:180: [First][<<] [2] [3] [4] [5] [6] [>>] [End]